Compounding Pharmacy · Est. 2009 · Orlando, FL · Both

Olympia Pharmaceuticals Review

Olympia Pharmaceuticals (Olympia Pharmacy; legal entity OPS International, Inc.) is a dual 503A/503B compounding pharmacy based in Orlando, Florida, founded in 2009 and licensed in 49 states. It is FDA-registered as a 503B outsourcing facility and produces sterile injectable compounds including GLP-1 medications. FDA has issued Form 483s to the 503B facility in 2022, 2024, 2025, and September 2026.

Olympia's Orlando outsourcing facility received its latest FDA Form 483 in September 2026, and FDA's list still shows that action as open; our entry on how 503B outsourcing facilities are regulated explains what those inspections cover. LifeMD is among the telehealth services that name Olympia, and ThisGen Wellness says Olympia dispenses its prescriptions to patients in New York.

5 FDA, state or legal actions on record. Most recent: FDA Form 483 (Sep 3, 2026) — see the full record below.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

BothPCABFDA Registered 503B
Location: Orlando, FL
8.3/10
★★★★☆4.2/5

Editorial score out of 10 · methodology

Regulatory Actions

FDA Form 483 issued to OPS International, Inc. (dba Olympia Pharmacy), Orlando, FL 503B facility.
FDA regulatory meeting held with OPS International, Inc. (dba Olympia Pharmacy), Orlando, FL 503B facility.
FDA Form 483 issued to the Orlando, FL 503B facility.
Amended FDA Form 483 issued to the Orlando, FL 503B facility.
FDA Form 483 issued to the Orlando, FL 503B facility; FDA's outsourcing-facility list shows the action as open.

Telehealth Providers Sourcing From This Pharmacy

These telehealth brands are reported to fulfill some or all compounded GLP-1 prescriptions through Olympia Pharmaceuticals. Sourcing arrangements can change over time.

7.7/ 10

Mochi Health

Best for: insurance help for brand-name GLP-1s, or self-pay compounded GLP-1 priced by dose

★★★★☆3.9/5

Editorial score · methodology

$139/mosemaglutide
+ added fee
$169/motirzepatide
+ added fee
SemaglutideTirzepatide
7.1/ 10

LifeMD

Best for: people with commercial insurance who want brand-name GLP-1s plus help getting coverage

★★★★☆3.6/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
SemaglutideTirzepatide

Top-Rated GLP-1 Partners

Not sourced from Olympia Pharmaceuticals — these are our highest-scored vetted GLP-1 telehealth partners, if you'd rather start with a provider we've walked through end to end.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

No insurance needed · HSA/FSA eligible · vetted by our editors

7.7

Ro

FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

Starting price: $149/mo (+ required membership)

Get started →Read review Ro →
8.3

Collective

The lowest flat medication price if you can absorb an annual membership fee

Starting price: $59/mo (+ required membership)

Get started →Read review Collective →
8.3

CoreAge Rx

Lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

Starting price: $79/mo (“starting at” price)

Get started →Read review CoreAge Rx →
7.8

Embody

Low flat-rate compounded GLP-1 pricing at every dose

Starting price: $79/mo (sale price)

Get started →Read review Embody →

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

PCAB
Pharmacy Compounding Accreditation Board — voluntary third-party accreditation (operated by ACHC) auditing the pharmacy against nationally recognized quality and safety standards for sterile and non-sterile compounding.
FDA Registered 503B
Registered directly with the FDA as a 503B outsourcing facility. Subject to FDA inspection and required to follow cGMP standards.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed

Olympia Pharmaceuticals has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.

External Reviews

Google Reviews
3.6 / 5.0
Based on 110 reviews

Weight Loss Rankings Score Breakdown

Accreditation & Compliance9/10
Regulatory Standing5/10
State CoverageNot published
GLP-1 Production10/10
Track Record9/10

Scores are independently researched. See our methodology for details.

Low confidence · Pharmacy details last verified November 2026 · How we verify provider data

Frequently Asked Questions

Olympia Pharmaceuticals is a Both compounding pharmacy based in Orlando, FL that has been operating since 2009. It holds PCAB accreditation, a voluntary third-party quality standard for compounding pharmacies. Note: our records show 5 documented regulatory action(s) — see the Regulatory Actions section below.
Olympia Pharmaceuticals is headquartered in Orlando, FL. It has not published a state-by-state licensure list, so verify licensure for your state with your state board of pharmacy.
Olympia Pharmaceuticals produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a Both pharmacy, it operates both a patient-specific 503A division and an FDA-registered 503B outsourcing facility.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources & methodology (as of November 2026)
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.